[HTML][HTML] Combination therapy in combating cancer
RB Mokhtari, TS Homayouni, N Baluch… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Combination therapy, a treatment modality that combines two or more therapeutic agents, is
a cornerstone of cancer therapy. The amalgamation of anti-cancer drugs enhances efficacy …
a cornerstone of cancer therapy. The amalgamation of anti-cancer drugs enhances efficacy …
Retinoic acid receptors: from molecular mechanisms to cancer therapy
Retinoic acid (RA), the major bioactive metabolite of retinol or vitamin A, induces a spectrum
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …
Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
BJ Wouters, R Delwel - Blood, The Journal of the American …, 2016 - ashpublications.org
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is
a heterogeneous malignancy characterized by distinct genetic abnormalities. Recent …
a heterogeneous malignancy characterized by distinct genetic abnormalities. Recent …
Acute lymphoblastic leukemia displays a distinct highly methylated genome
DNA methylation is tightly regulated during development and is stably maintained in healthy
cells. In contrast, cancer cells are commonly characterized by a global loss of DNA …
cells. In contrast, cancer cells are commonly characterized by a global loss of DNA …
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
RBM15, an RNA binding protein, determines cell-fate specification of many tissues including
blood. We demonstrate that RBM15 is methylated by protein arginine methyltransferase 1 …
blood. We demonstrate that RBM15 is methylated by protein arginine methyltransferase 1 …
Clonal evolution in leukemia
AA Ferrando, C Lopez-Otin - Nature medicine, 2017 - nature.com
Human leukemias are liquid malignancies characterized by diffuse infiltration of the bone
marrow by transformed hematopoietic progenitors. The accessibility of tumor cells obtained …
marrow by transformed hematopoietic progenitors. The accessibility of tumor cells obtained …
Targeting cell cycle regulators in hematologic malignancies
E Aleem, RJ Arceci - Frontiers in cell and developmental biology, 2015 - frontiersin.org
Hematologic malignancies represent the fourth most frequently diagnosed cancer in
economically developed countries. In hematologic malignancies normal hematopoiesis is …
economically developed countries. In hematologic malignancies normal hematopoiesis is …
Problems, challenges and promises: perspectives on precision medicine
DJ Duffy - Briefings in bioinformatics, 2016 - academic.oup.com
The 'precision medicine (systems medicine)'concept promises to achieve a shift to future
healthcare systems with a more proactive and predictive approach to medicine, where the …
healthcare systems with a more proactive and predictive approach to medicine, where the …
The emerging role of H3K9me3 as a potential therapeutic target in acute myeloid leukemia
L Monaghan, ME Massett, RP Bunschoten… - Frontiers in …, 2019 - frontiersin.org
Growing evidence has demonstrated that epigenetic dysregulation is a common
pathological feature in human cancer cells. Global alterations in the epigenetic landscape …
pathological feature in human cancer cells. Global alterations in the epigenetic landscape …
[HTML][HTML] Epigenetics in pediatric acute lymphoblastic leukemia
J Nordlund, AC Syvänen - Seminars in cancer biology, 2018 - Elsevier
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. ALL arises
from the malignant transformation of progenitor B-and T-cells in the bone marrow into …
from the malignant transformation of progenitor B-and T-cells in the bone marrow into …